Risk of molecular recurrence after tyrosine kinase inhibitor discontinuation in chronic myeloid leukaemia patients: a systematic review of literature with a meta‐analysis of studies over the last ten years
2020 ◽
Vol 189
(3)
◽
pp. 452-468
◽
2020 ◽
2016 ◽
Vol 91
(11)
◽
pp. E480-E481
◽
2015 ◽
Vol 169
(5)
◽
pp. 683-688
◽
2013 ◽
Vol 20
(Suppl 1)
◽
pp. A4.3-A5
CP-214 Adherence to tyrosine kinase inhibitor treatments in chronic myeloid leukaemia: A pilot study
2016 ◽
Vol 23
(Suppl 1)
◽
pp. A94.2-A95